Alkem Laboratories Limited — Updates, 14-02-2026: General Updates
14-02-2026 | 12:02 pm
14-02-2026 | 12:02 pm
Alkem's subsidiary Enzene had a USFDA inspection with 6 procedural observations. Crucially, zero data integrity issues were found. Enzene is initiating corrective actions and submitting its response.
No comments yet. Be the first to comment!
